Martingale Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.5M | Buy |
163,305
+4,751
| +3% | +$1.05M | 0.89% | 14 |
|
|
2025
Q4 | $36.2M | Buy |
158,554
+5,147
| +3% | +$1.17M | 0.92% | 17 |
|
|
2025
Q3 | $35.5M | Sell |
153,407
-14,724
| -9% | -$3M | 0.89% | 18 |
|
|
2025
Q2 | $31.2M | Buy |
168,131
+41,625
| +33% | +$7.74M | 0.77% | 28 |
|
|
2025
Q1 | $26.5M | Sell |
126,506
-23,727
| -16% | -$4.61M | 0.67% | 37 |
|
|
2024
Q4 | $26.7M | Sell |
150,233
-9,495
| -6% | -$1.75M | 0.65% | 42 |
|
|
2024
Q3 | $31.5M | Sell |
159,728
-35,846
| -18% | -$6.69M | 0.72% | 34 |
|
|
2024
Q2 | $33.5M | Sell |
195,574
-11,874
| -6% | -$1.97M | 0.73% | 37 |
|
|
2024
Q1 | $37.8M | Sell |
207,448
-16,483
| -7% | -$2.84M | 0.75% | 34 |
|
|
2023
Q4 | $34.7M | Sell |
223,931
-10,520
| -4% | -$1.53M | 0.71% | 41 |
|
|
2023
Q3 | $34.9M | Sell |
234,451
-2,465
| -1% | -$362K | 0.74% | 35 |
|
|
2023
Q2 | $31.9M | Sell |
236,916
-3,401
| -1% | -$499K | 0.62% | 51 |
|
|
2023
Q1 | $38.3M | Buy |
240,317
+2,956
| +1% | +$452K | 0.74% | 35 |
|
|
2022
Q4 | $38.4M | Sell |
237,361
-17,472
| -7% | -$2.68M | 0.75% | 34 |
|
|
2022
Q3 | $34.2M | Buy |
254,833
+7,493
| +3% | +$1.08M | 0.68% | 42 |
|
|
2022
Q2 | $37.9M | Sell |
247,340
-22,297
| -8% | -$3.41M | 0.69% | 42 |
|
|
2022
Q1 | $43.7M | Buy |
269,637
+128,934
| +92% | +$18.7M | 0.66% | 43 |
|
|
2021
Q4 | $19.1M | Buy |
140,703
+103,923
| +283% | +$12.3M | 0.24% | 134 |
|
|
2021
Q3 | $3.97M | Buy |
36,780
+6,009
| +20% | +$687K | 0.05% | 193 |
|
|
2021
Q2 | $3.47M | Buy |
+30,771
| New | +$3.47M | 0.04% | 207 |
|
|
2021
Q1 | – | Sell |
-24,232
| Closed | -$2.6M | – | 837 |
|
|
2020
Q4 | $2.6M | Sell |
24,232
-6,505
| -21% | -$625K | 0.03% | 266 |
|
|
2020
Q3 | $2.69M | Hold |
30,737
| – | – | 0.03% | 343 |
|
|
2020
Q2 | $3.02M | Sell |
30,737
-4,199
| -12% | -$370K | 0.04% | 424 |
|
|
2020
Q1 | $2.66M | Sell |
34,936
-2,602
| -7% | -$222K | 0.04% | 432 |
|
|
2019
Q4 | $3.32M | Sell |
37,538
-18,702
| -33% | -$1.55M | 0.03% | 477 |
|
|
2019
Q3 | $4.26M | Sell |
56,240
-18,901
| -25% | -$1.3M | 0.04% | 418 |
|
|
2019
Q2 | $5.46M | Hold |
75,141
| – | – | 0.06% | 355 |
|
|
2019
Q1 | $6.06M | Buy |
75,141
+9
| +0% | +$736 | 0.07% | 313 |
|
|
2018
Q4 | $6.93M | Sell |
75,132
-1,201
| -2% | -$106K | 0.09% | 230 |
|
|
2018
Q3 | $7.22M | Sell |
76,333
-9,105
| -11% | -$863K | 0.08% | 232 |
|
|
2018
Q2 | $7.92M | Buy |
85,438
+1,398
| +2% | +$137K | 0.1% | 202 |
|
|
2018
Q1 | $7.96M | Sell |
84,040
-700
| -0.8% | -$76.9K | 0.1% | 197 |
|
|
2017
Q4 | $8.2M | Sell |
84,740
-296
| -0.3% | -$27.9K | 0.11% | 198 |
|
|
2017
Q3 | $7.56M | Buy |
85,036
+2,705
| +3% | +$206K | 0.1% | 208 |
|
|
2017
Q2 | $5.97M | Buy |
82,331
+736
| +0.9% | +$49.5K | 0.08% | 250 |
|
|
2017
Q1 | $5.32M | Sell |
81,595
-53,172
| -39% | -$3.34M | 0.08% | 280 |
|
|
2016
Q4 | $8.44M | Buy |
134,767
+3,487
| +3% | +$213K | 0.12% | 202 |
|
|
2016
Q3 | $8.28M | Buy |
131,280
+26,396
| +25% | +$1.71M | 0.12% | 201 |
|
|
2016
Q2 | $6.49M | Buy |
104,884
+61,792
| +143% | +$3.77M | 0.11% | 223 |
|
|
2016
Q1 | $2.46M | Buy |
43,092
+5,607
| +15% | +$313K | 0.05% | 299 |
|
|
2015
Q4 | $2.22M | Sell |
37,485
-5,017
| -12% | -$289K | 0.05% | 296 |
|
|
2015
Q3 | $2.31M | Sell |
42,502
-45,270
| -52% | -$2.95M | 0.06% | 286 |
|
|
2015
Q2 | $5.9M | Sell |
87,772
-272,986
| -76% | -$17.8M | 0.14% | 208 |
|
|
2015
Q1 | $21.1M | Buy |
360,758
+159,671
| +79% | +$9.65M | 0.5% | 42 |
|
|
2014
Q4 | $13.2M | Buy |
201,087
+24,002
| +14% | +$1.51M | 0.36% | 71 |
|
|
2014
Q3 | $10.2M | Sell |
177,085
-261,230
| -60% | -$14.5M | 0.32% | 86 |
|
|
2014
Q2 | $24.7M | Buy |
438,315
+26,135
| +6% | +$1.37M | 0.77% | 17 |
|
|
2014
Q1 | $21.2M | Buy |
412,180
+92,213
| +29% | +$4.66M | 0.72% | 18 |
|
|
2013
Q4 | $16.9M | Sell |
319,967
-8,779
| -3% | -$431K | 0.59% | 24 |
|
|
2013
Q3 | $14.7M | Buy |
328,746
+36,941
| +13% | +$1.64M | 0.52% | 32 |
|
|
2013
Q2 | $12.1M | Buy |
+291,805
| New | +$12.8M | 0.45% | 44 |
|
Other funds holding ABBV
VCM
VPM
Martingale Asset Management's ABBV Position: Q1 2026 in Review
Martingale Asset Management increased its AbbVie (ABBV) stake by 3% in Q1 2026, buying an estimated $1.05M and bringing the position to 163,305 shares worth $35.5M. The position accounts for 0.89% of the portfolio, ranked #14.
Martingale Asset Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $43.7M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Martingale Asset Management held 163,305 shares of AbbVie worth $35.5M as of Q1 2026.
- Martingale Asset Management bought 4,751 AbbVie shares in Q1 2026, an estimated $1.05M.
- AbbVie made up 0.89% of Martingale Asset Management's portfolio in Q1 2026, its #14 holding.
- Martingale Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- Martingale Asset Management's AbbVie position peaked at $43.7M in Q1 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.